Cargando…
Is the priority review voucher program stimulating new drug development for tropical diseases?
Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uni...
Autores principales: | Kerr, Kirk W., Henry, Thomas C., Miller, Kathleen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103519/ https://www.ncbi.nlm.nih.gov/pubmed/30092022 http://dx.doi.org/10.1371/journal.pntd.0006695 |
Ejemplares similares
-
The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
por: Aerts, Celine, et al.
Publicado: (2022) -
Correction to: The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
por: Aerts, Celine, et al.
Publicado: (2022) -
Priorities for the Priority Review Voucher
por: Ridley, David B.
Publicado: (2017) -
The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products
por: Berman, Jonathan, et al.
Publicado: (2017) -
Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade
por: Stefanakis, Rianna, et al.
Publicado: (2012)